 NCI-H1703(ICGE-NCI-H1703,IC-82482)
  NCI-H1703(ICGE-NCI-H1703,IC-82482)

Overview
        | Permits and Restrictions | |
|---|---|
| Organism | Homo sapiens, human | 
| Tissue | lung | 
| Cell Type | squamous cell | 
| Product Format | frozen | 
| Morphology | epithelial | 
| Culture Properties | adherent | 
| Biosafety Level | 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. | 
| Disease | lung; squamous cell; non-small cell lung cancer | 
| Age | 54 years adult | 
| Gender | male | 
| Ethnicity | Caucasian | 
| Storage Conditions | liquid nitrogen vapor phase | 
Properties
        | Derivation | NCI-H1703 was derived from a stage 1 lung squamous cell carcinoma of a 54-year-old Caucasian male smoker. | 
|---|---|
| Clinical Data | 
					54 years adult
				 
					Caucasian
				 
					male
				 
					The tissue donor was a smoker (50 pack years).
				 | 
Background
        | Complete Growth Medium | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%. | 
|---|---|
| Subculturing | Volumes are given for a 75 cm2 flask. Increase or decrease the amount of dissociation medium needed proportionally for culture vessels of other sizes. 
 
					Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
				 
					Medium Renewal: Two to three times weekly
				 | 
| Cryopreservation | 
					Freeze medium: Complete growth medium, 95%; DMSO, 5%
				 
					Storage temperature: liquid nitrogen vapor phase
				 | 








